{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:44:56Z","timestamp":1773801896498,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00246208"],"award-info":[{"award-number":["RS-2023-00246208"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00249115"],"award-info":[{"award-number":["RS-2023-00249115"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003661","name":"Korea Institute for Advancement of Technology","doi-asserted-by":"publisher","award":["RS-2025-02214034"],"award-info":[{"award-number":["RS-2025-02214034"]}],"id":[{"id":"10.13039\/501100003661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02197-7","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:19:40Z","timestamp":1773746380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel small molecule KMU-11361 attenuates rheumatoid arthritis by mechanistic inhibition of the TAK1\u2013NF-\u03baB\u2013NLRP3 axis"],"prefix":"10.1007","volume":"75","author":[{"given":"Hye Suk","family":"Baek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deokhyeon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Sukbong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Il","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungik","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunho","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hyon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Nam","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunsu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"5","key":"2197_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/joim.13058","volume":"287","author":"L Klareskog","year":"2020","unstructured":"Klareskog L, R\u00f6nnelid J, Saevarsdottir S, Padyukov L, Alfredsson L. The importance of differences: on environment and its interactions with genes and immunity in the causation of rheumatoid arthritis. J Intern Med. 2020;287(5):514\u201333. https:\/\/doi.org\/10.1111\/joim.13058.","journal-title":"J Intern Med"},{"issue":"1","key":"2197_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","volume":"8","author":"Q Ding","year":"2023","unstructured":"Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M, Cai J, Rose P, Mao J, Zhu Y.Z. Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Therapy. 2023;8(1):68. https:\/\/doi.org\/10.1038\/s41392-023-01331-9.","journal-title":"Signal Transduct Target Therapy"},{"issue":"10","key":"2197_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41584-022-00827-y","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, Alpizar-Rodriguez D, Lauper K. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18(10):591\u2013602. https:\/\/doi.org\/10.1038\/s41584-022-00827-y.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"2197_CR4","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"Global regional, and national burden of rheumatoid arthritis","year":"2023","unstructured":"Global regional, and national burden of rheumatoid arthritis. 1990\u20132020, projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(10):e594\u2013610. https:\/\/doi.org\/10.1016\/s2665-9913(23)00211-4","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"2197_CR5","doi-asserted-by":"publisher","first-page":"e11074","DOI":"10.7759\/cureus.11074","volume":"12","author":"RA Ruggiero","year":"2020","unstructured":"Ruggiero RA, Iqbal QZ, Zia Z, Mishiyev D, Khalid I. A case of rheumatoid arthritis-associated interstitial lung disease - an unfortunate complication of untreated rheumatoid arthritis! Cureus. 2020;12(10):e11074. . https:\/\/doi.org\/10.7759\/cureus.11074","journal-title":"Cureus"},{"issue":"3","key":"2197_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","volume":"18","author":"Y Tanaka","year":"2022","unstructured":"Tanaka Y, Luo Y, O\u2019Shea JJ, Nakayamada S. Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. Nat Rev Rheumatol. 2022;18(3):133\u201345. https:\/\/doi.org\/10.1038\/s41584-021-00726-8.","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"2197_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41577-023-00877-7","volume":"23","author":"L Castelo-Soccio","year":"2023","unstructured":"Castelo-Soccio L, Kim H, Gadina M, Schwartzberg P.L., Laurence A, O\u2019Shea J.J. Protein kinases: drug targets for immunological disorders. Nat Rev Immunol. 2023;23(12):787\u2013806. https:\/\/doi.org\/10.1038\/s41577-023-00877-7.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2197_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.therap.2021.12.002","volume":"77","author":"S Bouchet","year":"2022","unstructured":"Bouchet S, Molimard M. Pharmacokinetics and therapeutic drug monitoring of anticancer protein\/kinase inhibitors. Therapie. 2022;77(2):157\u201370. https:\/\/doi.org\/10.1016\/j.therap.2021.12.002.","journal-title":"Therapie"},{"issue":"8","key":"2197_CR9","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00011-024-01904-6","volume":"73","author":"HS Baek","year":"2024","unstructured":"Baek HS, Hong VS, Kang H, Lee SJ, Lee JY, Kang H, Jeong S, Jung H, Park JW, Kwon TK, Son CN, Kim SH, Lee J, Kim KS, Kim S. Anti-rheumatic property and physiological safety of KMU-11342 in in vitro and in vivo models. Inflamm Res. 2024;73(8):1371\u201391. . https:\/\/doi.org\/10.1007\/s00011-024-01904-6","journal-title":"Inflamm Res"},{"issue":"14","key":"2197_CR10","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1016\/j.bmcl.2011.05.081","volume":"21","author":"J Lee","year":"2011","unstructured":"Lee J, Kim K-H, Jeong S. Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2 inhibitors. Bioorg Med Chem Lett. 2011;21(14):4203\u20135. https:\/\/doi.org\/10.1016\/j.bmcl.2011.05.081.","journal-title":"Bioorg Med Chem Lett"},{"key":"2197_CR11","doi-asserted-by":"publisher","first-page":"15221","DOI":"10.1002\/0471142735.im1522s81","volume":"Chapter 15","author":"PA Monach","year":"2008","unstructured":"Monach P.A., Mathis D, Benoist C. The K\/BxN arthritis model. Curr Protoc Immunol. 2008;Chapter 15:15221\u2013152212. https:\/\/doi.org\/10.1002\/0471142735.im1522s81.","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"2197_CR12","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1186\/ar4143","volume":"15","author":"P Martin","year":"2013","unstructured":"Martin P, Talabot-Ayer D, Seemayer CA, Vigne S, Lamacchia C, Rodriguez E, Finckh A, Smith DE, Gabay C, Palmer G. Disease severity in K\/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency. Arthritis Res Ther. 2013;15(1):R13. . https:\/\/doi.org\/10.1186\/ar4143","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"2197_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/s1074-7613(00)80045-x","volume":"10","author":"AS Korganow","year":"1999","unstructured":"Korganow A.S., Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali J.L., Benoist C, Mathis D. From systemic T cell self-reactivity to organ-specific autoimmune disease via Immunoglobulins. Immunity. 1999;10(4):451\u201361. https:\/\/doi.org\/10.1016\/s1074-7613(00)80045-x.","journal-title":"Immunity"},{"issue":"1","key":"2197_CR14","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.1038\/s41598-019-44512-9","volume":"9","author":"PM L\u00fcbcke","year":"2019","unstructured":"L\u00fcbcke PM, Ebbers MNB, Volzke J, Bull J, Kneitz S, Engelmann R, Lang H, Kreikemeyer B, M\u00fcller-Hilke B. Periodontal treatment prevents arthritis in mice and methotrexate ameliorates periodontal bone loss. Sci Rep. 2019;9(1):8128. https:\/\/doi.org\/10.1038\/s41598-019-44512-9.","journal-title":"Sci Rep"},{"key":"2197_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ebiom.2018.11.005","volume":"38","author":"SJ Woo","year":"2018","unstructured":"Woo SJ, Noh HS, Lee NY, Cheon YH, Yi SM, Jeon HM, Bae EJ, Lee SI, Park BH. Myeloid sirtuin 6 deficiency accelerates experimental rheumatoid arthritis by enhancing macrophage activation and infiltration into synovium. EBioMedicine. 2018;38:228\u201337. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.005","journal-title":"EBioMedicine"},{"issue":"1","key":"2197_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res. 2000;28(1):235\u201342.","journal-title":"Nucleic Acids Res"},{"key":"2197_CR17","doi-asserted-by":"publisher","first-page":"108420","DOI":"10.1016\/j.compbiolchem.2025.108420","volume":"117","author":"D Yoon","year":"2025","unstructured":"Yoon D, Lee H. In Silico discovery of novel compounds for FAK activation using virtual screening, AI-based prediction, and molecular dynamics. Comput Biol Chem. 2025;117:108420. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108420.","journal-title":"Comput Biol Chem"},{"key":"2197_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle N.M., Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open babel: an open chemical toolbox. J Cheminform. 2011;3:33. https:\/\/doi.org\/10.1186\/1758-2946-3-33.","journal-title":"J Cheminform"},{"key":"2197_CR19","unstructured":"Shermukhamedov S, Mamurjonova D, Probst M. Structure to property: chemical element embeddings and a deep learning approach for accurate prediction of chemical properties, arXiv preprint arXiv:2309.09355 (2023)."},{"issue":"2","key":"2197_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1039\/c7sc02664a","volume":"9","author":"Z Wu","year":"2018","unstructured":"Wu Z, Ramsundar B, Feinberg EN, Gomes J, Geniesse C, Pappu AS, Leswing K, Pande V. MoleculeNet: a benchmark for molecular machine learning. Chem Sci. 2018;9(2):513\u201330. https:\/\/doi.org\/10.1039\/c7sc02664a.","journal-title":"Chem Sci"},{"key":"2197_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fenvs.2015.00085","volume":"3","author":"R Huang","year":"2016","unstructured":"Huang R, Xia M, Nguyen D-T, Zhao T, Sakamuru S, Zhao J, Shahane SA, Rossoshek A, Simeonov A. Tox21Challenge to build predictive models of nuclear receptor and stress response pathways as mediated by exposure to environmental chemicals and drugs. Front Environ Sci. 2016;3:85.","journal-title":"Front Environ Sci"},{"key":"2197_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fenvs.2015.00080","volume":"3","author":"A Mayr","year":"2016","unstructured":"Mayr A, Klambauer G, Unterthiner T, Hochreiter S. DeepTox: toxicity prediction using deep learning. Front Environ Sci. 2016;3:80.","journal-title":"Front Environ Sci"},{"key":"2197_CR23","unstructured":"Westerfield M. The Zebrafish Book; A guide for the laboratory use of zebrafish (Danio rerio), (No Title) (2007)."},{"key":"2197_CR24","doi-asserted-by":"publisher","first-page":"114499","DOI":"10.1016\/j.intimp.2025.114499","volume":"153","author":"M Hu","year":"2025","unstructured":"Hu M, Zhou Y, Yao Z, Tang Y, Zhang Y, Liao J, Cai X, Liu L. T cell dysregulation in rheumatoid arthritis: recent advances and natural product interventions. Int Immunopharmacol. 2025;153:114499. https:\/\/doi.org\/10.1016\/j.intimp.2025.114499.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"2197_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.tips.2012.06.007","volume":"33","author":"H Sakurai","year":"2012","unstructured":"Sakurai H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol Sci. 2012;33(10):522\u201330. https:\/\/doi.org\/10.1016\/j.tips.2012.06.007.","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"2197_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/sj.cdd.4401845","volume":"13","author":"ML Schmitz","year":"2006","unstructured":"Schmitz ML, Krappmann D. Controlling NF-kappaB activation in T cells by costimulatory receptors. Cell Death Differ. 2006;13(5):834\u201342. https:\/\/doi.org\/10.1038\/sj.cdd.4401845","journal-title":"Cell Death Differ"},{"issue":"7","key":"2197_CR27","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.str.2013.04.025","volume":"21","author":"C Shu","year":"2013","unstructured":"Shu C, Sankaran B, Chaton CT, Herr AB, Mishra A, Peng J, Li P. Structural insights into the functions of TBK1 in innate antimicrobial immunity. Structure. 2013;21(7):1137\u201348.","journal-title":"Structure"},{"issue":"21","key":"2197_CR28","doi-asserted-by":"publisher","first-page":"14136","DOI":"10.1074\/jbc.M109.000414","volume":"284","author":"K Clark","year":"2009","unstructured":"Clark K, Plater L, Peggie M, Cohen P. Use of the Pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and I\u03baB kinase \u03f5: A distinct upstream kinase mediates Ser-172 phosphorylation and activation. J Biol Chem. 2009;284(21):14136\u201346.","journal-title":"J Biol Chem"},{"issue":"15","key":"2197_CR29","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1158\/0008-5472.CAN-05-0574","volume":"65","author":"K Godl","year":"2005","unstructured":"Godl K, Gruss OJ, Eickhoff J, Wissing J, Blencke S, Weber M, Degen H, Brehmer D, Orfi L, Horvath Z, Keri G, Muller S, Cotten M, Ullrich A, Daub H. Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling. Cancer Res. 2005;65(15):6919\u201326. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0574.","journal-title":"Cancer Res"},{"issue":"1","key":"2197_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/acb-2014-0001","volume":"4","author":"M Czerkies","year":"2014","unstructured":"Czerkies M, Kwiatkowska K. Toll-Like receptors and their contribution to innate immunity: focus on TLR4 activation by lipopolysaccharide. Adv Cell Biology. 2014;4(1):1\u201323. https:\/\/doi.org\/10.2478\/acb-2014-0001.","journal-title":"Adv Cell Biology"},{"key":"2197_CR31","doi-asserted-by":"publisher","first-page":"1228176","DOI":"10.3389\/fimmu.2023.1228176","volume":"14","author":"H Yin","year":"2023","unstructured":"Yin H, Liu N, Sigdel KR, Duan L, Corrigendum. Role of NLRP3 inflammasome in rheumatoid arthritis. Front Immunol. 2023;14:1228176. https:\/\/doi.org\/10.3389\/fimmu.2023.1228176","journal-title":"Front Immunol"},{"key":"2197_CR32","doi-asserted-by":"publisher","unstructured":"Huang JB, Chen ZR, Yang SL, Hong FF. Nitric oxide synthases in rheumatoid arthritis. Molecules. 2023;28(11). https:\/\/doi.org\/10.3390\/molecules28114414.","DOI":"10.3390\/molecules28114414"},{"issue":"7","key":"2197_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu N, Takayanagi H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat Rev Rheumatol. 2022;18(7):415\u201329. https:\/\/doi.org\/10.1038\/s41584-022-00793-5.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"2197_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.31138\/mjr.20230801.oo","volume":"34","author":"M Jahid","year":"2023","unstructured":"Jahid M, U Khan K, Rehan Ul H, S Ahmed R. Overview of rheumatoid arthritis and scientific Understanding of the disease. Mediterr J Rheumatol. 2023;34(3):284\u201391. https:\/\/doi.org\/10.31138\/mjr.20230801.oo.","journal-title":"Mediterr J Rheumatol"},{"key":"2197_CR35","doi-asserted-by":"publisher","unstructured":"Mueller AL, Payandeh Z, Mohammadkhani N, Mubarak S.M.H., Zakeri A, Alagheband Bahrami A, Brockmueller A, Shakibaei M. Recent advances in Understanding the pathogenesis of rheumatoid arthritis: new treatment strategies. Cells. 2021;10(11). https:\/\/doi.org\/10.3390\/cells10113017.","DOI":"10.3390\/cells10113017"},{"key":"2197_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q., Wang Y., Xu D., Nossent J., Pavlos N.J., Xu J. Rheumatoid arthritis: pathological mechanisms and modern Pharmacologic therapies. Bone Res. 2018;6:15. https:\/\/doi.org\/10.1038\/s41413-018-0016-9.","journal-title":"Bone Res"},{"key":"2197_CR37","doi-asserted-by":"publisher","first-page":"176437","DOI":"10.1016\/j.ejphar.2024.176437","volume":"969","author":"LE Chaffey","year":"2024","unstructured":"Chaffey LE, Roberti A, Bowman A, O\u2019Brien CJ, Som L, Purvis GS, Greaves DR. Drug repurposing screen identifies novel anti-inflammatory activity of Sunitinib in macrophages. Eur J Pharmacol. 2024;969:176437. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176437.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2197_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1124\/jpet.113.208223","volume":"349","author":"L Wollin","year":"2014","unstructured":"Wollin L, Maillet I, Quesniaux V, Holweg A, Ryffel B. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther. 2014;349(2):209\u201320. https:\/\/doi.org\/10.1124\/jpet.113.208223.","journal-title":"J Pharmacol Exp Ther"},{"key":"2197_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fimmu.2016.00213","volume":"7","author":"AD Christensen","year":"2016","unstructured":"Christensen AD, Haase C, Cook AD, Hamilton JA. K\/BxN Serum-transfer arthritis as a model for human inflammatory arthritis. Front Immunol. 2016;7:213. https:\/\/doi.org\/10.3389\/fimmu.2016.00213","journal-title":"Front Immunol"},{"issue":"5","key":"2197_CR40","first-page":"429","volume":"48","author":"CM Weyand","year":"2000","unstructured":"Weyand CM, Bryl E, Goronzy JJ. The role of T cells in rheumatoid arthritis. Arch Immunol Ther Exp (Warsz). 2000;48(5):429\u201335.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"1","key":"2197_CR41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/art.11487","volume":"50","author":"J Zwerina","year":"2004","unstructured":"Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum. 2004;50(1):277\u201390. https:\/\/doi.org\/10.1002\/art.11487","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2197_CR42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1302\/2046-3758.117.BJR-2021-0594.R1","volume":"11","author":"P Luo","year":"2022","unstructured":"Luo P, Wang P, Xu J, Hou W, Xu P, Xu K, Liu L. Immunomodulatory role of T helper cells in rheumatoid arthritis: a comprehensive research review. Bone Joint Res. 2022;11(7):426\u201338. https:\/\/doi.org\/10.1302\/2046-3758.117.Bjr-2021-0594.R1","journal-title":"Bone Joint Res"},{"issue":"14","key":"2197_CR43","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1016\/j.bmcl.2011.05.081","volume":"21","author":"J Lee","year":"2011","unstructured":"Lee J, Kim KH, Jeong S. Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2 inhibitors. Bioorg Med Chem Lett. 2011;21(14):4203\u20135. https:\/\/doi.org\/10.1016\/j.bmcl.2011.05.081","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"2197_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbapap.2007.09.016","volume":"1784","author":"R Akella","year":"2008","unstructured":"Akella R, Moon TM, Goldsmith EJ. Unique MAP Kinase binding sites. Biochim Biophys Acta. 2008;1784(1):48\u201355. https:\/\/doi.org\/10.1016\/j.bbapap.2007.09.016","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"2197_CR45","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jmb.2005.09.098","volume":"354","author":"K Brown","year":"2005","unstructured":"Brown K, Vial SC, Dedi N, Long JM, Dunster NJ, Cheetham GM. Structural basis for the interaction of TAK1 kinase with its activating protein Table 1. J Mol Biol. 2005;354(5):1013\u201320. https:\/\/doi.org\/10.1016\/j.jmb.2005.09.098","journal-title":"J Mol Biol"},{"issue":"3","key":"2197_CR46","doi-asserted-by":"publisher","first-page":"e4902","DOI":"10.1002\/pro.4902","volume":"33","author":"A Meller","year":"2024","unstructured":"Meller A, Kelly D, Smith LG, Bowman GR. Toward physics-based precision medicine: exploiting protein dynamics to design new therapeutics and interpret variants. Protein Sci. 2024;33(3):e4902.","journal-title":"Protein Sci"},{"issue":"5","key":"2197_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1389450119666181022153016","volume":"20","author":"S Saikia","year":"2019","unstructured":"Saikia S, Bordoloi M. Molecular Docking: challenges, advances and its use in drug discovery perspective. Curr Drug Targets. 2019;20(5):501\u201321. https:\/\/doi.org\/10.2174\/1389450119666181022153016","journal-title":"Curr Drug Targets"},{"key":"2197_CR48","doi-asserted-by":"publisher","first-page":"734749","DOI":"10.3389\/fcell.2021.734749","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang W, Gao W, Zhu Q, Alasbahi A, Seki E, Yang L. TAK1: a molecular link between liver inflammation, fibrosis, steatosis, and carcinogenesis. Front Cell Dev Biol. 2021;9:734749. https:\/\/doi.org\/10.3389\/fcell.2021.734749","journal-title":"Front Cell Dev Biol"},{"key":"2197_CR49","doi-asserted-by":"crossref","unstructured":"Kie\u0142bowski K, Plewa P, Bratborska AW, Bakinowska E, Pawlik A. JAK inhibitors in rheumatoid arthritis: immunomodulatory properties and clinical efficacy. Int J Mol Sci 2024;25(15). 10.3390\/ijms25158327.","DOI":"10.3390\/ijms25158327"},{"issue":"1","key":"2197_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","volume":"8","author":"Q Ding","year":"2023","unstructured":"Ding Q, Hu W, Wang R, Yang Q, Zhu M, Li M, Cai J, Rose P, Mao J, Zhu YZ. Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther. 2023;8(1):68. https:\/\/doi.org\/10.1038\/s41392-023-01331-9","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2197_CR51","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrrheum.2016.61","volume":"12","author":"LA Joosten","year":"2016","unstructured":"Joosten LA, Abdollahi-Roodsaz S, Dinarello CA, O\u2019Neill L, Netea MG. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol. 2016;12(6):344\u201357. https:\/\/doi.org\/10.1038\/nrrheum.2016.61","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"2197_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13075-015-0527-3","volume":"17","author":"AR Noort","year":"2015","unstructured":"Noort AR, Tak PP, Tas SW. Non-canonical NF-\u03baB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? Arthritis Res Ther. 2015;17(1):15. https:\/\/doi.org\/10.1186\/s13075-015-0527-3","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2197_CR53","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/rheumatology\/kew393","volume":"56","author":"CX van der Maracle","year":"2017","unstructured":"Maracle CX, Kucharzewska P, Helder B, van der Horst C, Correa de Sampaio P, Noort AR, van Zoest K, Griffioen AW, Olsson H, Tas SW. Targeting non-canonical nuclear factor-\u03baB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis. Rheumatology (Oxford). 2017;56(2):294\u2013302. https:\/\/doi.org\/10.1093\/rheumatology\/kew393","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2197_CR54","doi-asserted-by":"publisher","first-page":"F38","DOI":"10.1152\/ajprenal.00590.2010","volume":"302","author":"C K\u00fcper","year":"2012","unstructured":"K\u00fcper C, Beck FX, Neuhofer W. Toll-like receptor 4 activates NF-\u03baB and MAP kinase pathways to regulate expression of proinflammatory COX-2 in renal medullary collecting duct cells. Am J Physiol Ren Physiol. 2012;302(1):F38\u201346. https:\/\/doi.org\/10.1152\/ajprenal.00590.2010","journal-title":"Am J Physiol Ren Physiol"},{"issue":"7","key":"2197_CR55","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1128\/IAI.00403-13","volume":"81","author":"JJ Lee","year":"2013","unstructured":"Lee JJ, Kim DH, Kim DG, Lee HJ, Min W, Rhee MH, Cho JY, Watarai M, Kim S. Toll-like receptor 4-linked Janus kinase 2 signaling contributes to internalization of Brucella abortus by macrophages. Infect Immun. 2013;81(7):2448\u201358. https:\/\/doi.org\/10.1128\/iai.00403-13","journal-title":"Infect Immun"},{"issue":"3","key":"2197_CR56","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.4049\/jimmunol.1203084","volume":"191","author":"H Wang","year":"2013","unstructured":"Wang H, Brown J, Gao S, Liang S, Jotwani R, Zhou H, Suttles J, Scott DA, Lamont RJ. The role of JAK-3 in regulating TLR-mediated inflammatory cytokine production in innate immune cells. J Immunol. 2013;191(3):1164\u201374. https:\/\/doi.org\/10.4049\/jimmunol.1203084","journal-title":"J Immunol"},{"key":"2197_CR57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461. https:\/\/doi.org\/10.3389\/fimmu.2014.00461","journal-title":"Front Immunol"},{"issue":"7","key":"2197_CR58","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1039\/D2BM01994A","volume":"11","author":"YM Lee","year":"2023","unstructured":"Lee YM, Lee S, Kim WJ. Nitric oxide scavengers based on o-phenylenediamine for the treatment of rheumatoid arthritis. Biomater Sci. 2023;11(7):2395\u2013404. https:\/\/doi.org\/10.1039\/d2bm01994a","journal-title":"Biomater Sci"},{"issue":"4","key":"2197_CR59","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/joca.1998.0237","volume":"7","author":"P Needleman","year":"1999","unstructured":"Needleman P, Manning PT. Interactions between the inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) pathways: implications for therapeutic intervention in osteoarthritis. Osteoarthr Cartil. 1999;7(4):367\u201370. https:\/\/doi.org\/10.1053\/joca.1998.0237v","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"2197_CR60","doi-asserted-by":"publisher","first-page":"518s","DOI":"10.1042\/bst025518s","volume":"25","author":"V Gilston","year":"1997","unstructured":"Gilston V, Jones HW, Soo CC, Coumbe A, Blades S, Kaltschmidt C, Baeuerle PA, Morris CJ, Blake DR, Winyard PG. NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation. Biochem Soc Trans. 1997;25(3):518s. https:\/\/doi.org\/10.1042\/bst025518s","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2197_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13317-020-00135-z","volume":"11","author":"L Nejatbakhsh Samimi","year":"2020","unstructured":"Nejatbakhsh Samimi L, Farhadi E, Tahmasebi MN, Jamshidi A, Sharafat Vaziri A, Mahmoudi M. NF-\u03baB signaling in rheumatoid arthritis with focus on fibroblast-like synoviocytes. Autoimmun Highlights 11(1) (2020) 11. https:\/\/doi.org\/10.1186\/s13317-020-00135-z","journal-title":"Autoimmun Highlights"},{"issue":"6","key":"2197_CR62","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1007\/s12035-024-04634-2","volume":"62","author":"H Liao","year":"2025","unstructured":"Liao H, Zheng J, Lu J, Shen HL. NF-kappaB signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential. Mol Neurobiol. 2025;62(6):6998\u20137021. https:\/\/doi.org\/10.1007\/s12035-024-04634-2","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2197_CR63","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","volume":"17","author":"C Choulaki","year":"2015","unstructured":"Choulaki C, Papadaki G, Repa A, Kampouraki E, Kambas K, Ritis K, Bertsias G, Boumpas DT, Sidiropoulos P. Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):257. https:\/\/doi.org\/10.1186\/s13075-015-0775-2","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2197_CR64","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cei.13167","volume":"194","author":"C Guo","year":"2018","unstructured":"Guo C, Fu R, Wang S, Huang Y, Li X, Zhou M, Zhao J, Yang N. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis. Clin Exp Immunol. 2018;194(2):231\u201343. https:\/\/doi.org\/10.1111\/cei.13167","journal-title":"Clin Exp Immunol"},{"key":"2197_CR65","doi-asserted-by":"publisher","first-page":"767512","DOI":"10.3389\/fimmu.2021.767512","volume":"12","author":"R Sakalyte","year":"2021","unstructured":"Sakalyte R, Denkovskij J, Bernotiene E, Stropuviene S, Mikulenaite SO, Kvederas G, Porvaneckas N, Tutkus V, Venalis A, Butrimiene I. The expression of inflammasomes NLRP1 and NLRP3, toll-like receptors, and vitamin D receptor in synovial fibroblasts from patients with different types of knee arthritis. Front Immunol. 2021;12:767512. https:\/\/doi.org\/10.3389\/fimmu.2021.767512","journal-title":"Front Immunol"},{"issue":"3","key":"2197_CR66","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s11033-021-06288-y","volume":"48","author":"S Berardi","year":"2021","unstructured":"Berardi S, Corrado A, Maruotti N, Cici D, Cantatore FP. Osteoblast role in the pathogenesis of rheumatoid arthritis. Mol Biol Rep. 2021;48(3):2843\u201352. https:\/\/doi.org\/10.1007\/s11033-021-06288-y","journal-title":"Mol Biol Rep"},{"issue":"6937","key":"2197_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337\u201342. https:\/\/doi.org\/10.1038\/nature01658","journal-title":"Nature"},{"key":"2197_CR68","doi-asserted-by":"crossref","unstructured":"Aureal M, Machuca-Gayet I, Coury F. Rheumatoid arthritis in the view of osteoimmunology. Biomolecules. 2020;11(1).10.3390\/biom11010048.","DOI":"10.3390\/biom11010048"},{"issue":"3","key":"2197_CR69","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11914-017-0358-z","volume":"15","author":"B Zhao","year":"2017","unstructured":"Zhao B. TNF Remodeling B. Curr Osteoporos Rep. 2017;15(3):126\u201334. https:\/\/doi.org\/10.1007\/s11914-017-0358-z","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"2197_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/25785826.2023.2220931","volume":"47","author":"K Yokota","year":"2024","unstructured":"Yokota K. Osteoclast differentiation in rheumatoid arthritis. Immunol Med. 2024;47(1):6\u201311. https:\/\/doi.org\/10.1080\/25785826.2023.2220931","journal-title":"Immunol Med"},{"issue":"4","key":"2197_CR71","doi-asserted-by":"publisher","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","volume":"21","author":"JH Kim","year":"2014","unstructured":"Kim JH, Kim N. Regulation of NFATc1 in osteoclast differentiation. J Bone Metab. 2014;21(4):233\u201341. https:\/\/doi.org\/10.11005\/jbm.2014.21.4.233","journal-title":"J Bone Metab"},{"issue":"8","key":"2197_CR72","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","volume":"20","author":"EE Patton","year":"2021","unstructured":"Patton EE, Zon LI, Langenau DM. Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials. Nat Rev Drug Discov. 2021;20(8):611\u201328. https:\/\/doi.org\/10.1038\/s41573-021-00210-8","journal-title":"Nat Rev Drug Discov"},{"key":"2197_CR73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.reprotox.2014.09.005","volume":"55","author":"NA Ducharme","year":"2015","unstructured":"Ducharme NA, Reif DM, Gustafsson JA, Bondesson M. Comparison of toxicity values across zebrafish early life stages and mammalian studies: implications for chemical testing. Reprod Toxicol. 2015;55:3\u201310. https:\/\/doi.org\/10.1016\/j.reprotox.2014.09.005","journal-title":"Reprod Toxicol"},{"issue":"6","key":"2197_CR74","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1042\/bst20190280","volume":"47","author":"ML Stoker","year":"2019","unstructured":"Stoker ML, Newport E, Hulit JC, West AP, Morten KJ. Impact of pharmacological agents on mitochondrial function: a growing opportunity? Biochem. Soc Trans. 2019;47(6):1757\u201372. https:\/\/doi.org\/10.1042\/bst20190280","journal-title":"Soc Trans"},{"key":"2197_CR75","doi-asserted-by":"publisher","first-page":"1017650","DOI":"10.3389\/fmed.2022.1017650","volume":"9","author":"L Cui","year":"2022","unstructured":"Cui L, Weiyao J, Chenghong S, Limei L, Xinghua Z, Bo Y, Xiaozheng D, Haidong W. Rheumatoid arthritis and mitochondrial homeostasis: The crossroads of metabolism and immunity. Front Med (Lausanne). 2022;9:1017650. https:\/\/doi.org\/10.3389\/fmed.2022.1017650","journal-title":"Front Med (Lausanne)"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02197-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02197-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02197-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:03:56Z","timestamp":1773792236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02197-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2197"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02197-7","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}